1Mehrdad M, Lottie SW. Lawrence D, et al. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity. Journal of Clinical Virology, 2001, 23(1): 1- 15.
2Boucher A, Lord H, Collette S, et al. Cytomegalovirus infection in kidney transplant recipients: evolution of approach through three eras. Transplant Proceedings, 2006, 38(10): 3506-3508.
3Jabs D, Martin B, Forman M, et al. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovims retinitis. J Infect Dis, 2001, 183(3) :333 - 336.
4Lurain N, Bhorade S, Pursell K, et al. Analysis and characterization of antiviral chug - resistant cytomegalovirus isolates from solid organ transplant recipients. J Infect Dis, 2002, 186(6) : 760 - 767.
5Gerna G, Baldanti F, Grossi P, et al. Diagnosis and monitoring Of human cytomegalovirus infection in transplant recipients. Rev Med Microbiol, 2001, 12 (2): 155- 162.
6Kruger RM, Shannon W, Arens M, et al. The impact of ganciclovir - resistant cytomegalovirus infection after lung transplantation. Transplantation, 1999, 68(9) : 1272 - 1279.
7Bruyn De, Whelan TP, Mulligan MS, et al. Invasive Pneumococcal Infections in Adult Lung Transplant Recipients. American Journal of Transplantation, 2004, 4(8) : 1366 - 1371 .
8Christoph S, Elisabeth P, Theresia P. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). Journal of Clinical Virology,2006,37:1-9.
9Baldanti F, Simoncini L, Sarasini A, et al. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Transplantation, 1998, 66(3): 324 - 330.
10Emery VC, Sabin CA, Hassan - Walker AF, et al. Viral - load kinetics and CMV disease. Lancet, 2000, 356:1353 - 1359.
